James Wilcox
Veterans Health Administration
6 Papers
11 Citations
James Wilcox is an academic researcher from Veterans Health Administration. The author has contributed to research in topics: Major depressive disorder & Aripiprazole. The author has an hindex of 3, co-authored 6 publications.
Chat about Author
Papers
Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.
Somaia Mohamed,Somaia Mohamed,Gary R. Johnson,Peijun Chen,Paul B. Hicks,Paul B. Hicks,Lori L. Davis,Lori L. Davis,Jean Yoon,Theresa Gleason,Julia E. Vertrees,Kimberly R. Weingart,Kimberly R. Weingart,Ilanit Tal,Alexandra Scrymgeour,David Lawrence,Beata Planeta,Michael E Thase,Grant D. Huang,Sidney Zisook,Sidney Zisook,Sanjai D. Rao,Sanjai D. Rao,Patricia Pilkinton,James Wilcox,Ali Iranmanesh,Mamta Sapra,George Jurjus,James P. Michalets,Muhammed Aslam,Thomas P. Beresford,Keith D. Anderson,Ronald Fernando,Sriram Ramaswamy,John Kasckow,Joseph Westermeyer,Gihyun Yoon,D. Cyril D’Souza,Gunnar Larson,William G. Anderson,Mary Klatt,Ayman Fareed,Shabnam I. Thompson,Carlos J. Carrera,Solomon S. Williams,Timothy M. Juergens,Lawrence J. Albers,Clifford S. Nasdahl,Gerardo Villarreal,Julia L. Winston,Cristobal A. Nogues,K. Ryan Connolly,Andre Tapp,Kari A. Jones,Gauri Khatkhate,Sheetal Marri,Trisha Suppes,Joseph M. LaMotte,Robin A. Hurley,Aimee R. Mayeda,Alexander B. Niculescu,Bernard A. Fischer,David Loreck,Nicholas Rosenlicht,Steven Lieske,Mitchell S. Finkel,John T. Little +66 more
TL;DR: Among a predominantly male population with major depressive disorder unresponsive to antidepressant treatment, augmentation with aripiprazole resulted in a statistically significant but only modestly increased likelihood of remission during 12 weeks of treatment compared with switching to bupropion monotherapy.
Cognitive Processing Therapy for Posttraumatic Stress Disorder Is Associated with Negligible Change in Subjective and Objective Sleep.
Patricia L. Haynes,Iva Skobic,Dana R. Epstein,Sarah E. Emert,Sairam Parthasarathy,Suzanne C. Perkins,James Wilcox +6 more
TL;DR: The findings support previous research demonstrating a need for independent clinical attention to address insomnia either before, during, or after PTSD treatment.
18
The Effect of Sleep Disorders, Sedating Medications, and Depression on Cognitive Processing Therapy Outcomes: A Fuzzy Set Qualitative Comparative Analysis.
Patricia L. Haynes,Sarah E. Emert,Dana R. Epstein,Suzanne C. Perkins,Sairam Parthasarathy,James Wilcox +5 more
TL;DR: It is suggested that sleep disorders are important factors to consider in theoretical discussions of who responds to CPT for PTSD, and recipes involving the absence of the relevant sleep disorder were associated with the highest coverage values.
9
Impact of Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic Augmentation for Major Depressive Disorder With a Prior Failed Treatment: VAST-D Randomized Clinical Trial
Somaia Mohamed,Gary R. Johnson,Varadan Sevilimedu,Sanjai D. Rao,Paul B. Hicks,Peijun Chen,Kimberly Lauro,George Jurjus,Patricia Pilkinton,Lori L. Davis,James Wilcox,Ali Iranmanesh,Mamta Sapra,Muhammad Aslam,James P. Michalets,Michael E Thase,Sidney Zisook,Csp# Vast-D Investigators +17 more
TL;DR: Although PTSD was associated with poorer overall outcomes, the presence of concurrent PTSD among Veterans in this trial did not affect the comparative effectiveness of medications on response, remission, or relapse after initial remission.
7